METOCLOPRAMIDE

METOCLOPRAMIDE was reported 77711 times

METOCLOPRAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTERISED TOMOGRAM THORAX 39 0.6500
1 FAMILY STRESS 1920 0.6186
2 EXTRAPYRAMIDAL DISORDER 11637 0.4682
3 TARDIVE DYSKINESIA 13206 0.4676
4 DYSTONIA 6685 0.3443
5 MULTIPLE INJURIES 2127 0.3375
6 NEUROGLYCOPENIA 33 0.3000
7 GRIMACING 222 0.2843
8 DEFORMITY 2327 0.2487
9 ECONOMIC PROBLEM 3756 0.2476
10 NERVOUS SYSTEM DISORDER 7177 0.2297
11 LYMPHOID TISSUE HYPOPLASIA 33 0.2157
12 THYMUS HYPOPLASIA 35 0.2011
13 EXCESSIVE EYE BLINKING 284 0.1920
14 VAGINAL FLATULENCE 53 0.1749
15 QUALITY OF LIFE DECREASED 2038 0.1517
16 ACTIVITIES OF DAILY LIVING IMPAIRED 2759 0.1392
17 PARKINSON'S DISEASE 332 0.1305
18 ESSENTIAL TREMOR 135 0.1210
19 AKATHISIA 1618 0.1185
20 PERIPHERAL CIRCULATORY FAILURE 45 0.1095
21 CHOREA 184 0.1067
22 DEPRESSION SUICIDAL 365 0.1053
23 COMPUTERISED TOMOGRAM THORAX ABNORMAL 71 0.1033
24 MOVEMENT DISORDER 2870 0.0893
25 INCORRECT DRUG ADMINISTRATION DURATION 2488 0.0884
26 STEREOTYPY 76 0.0806
27 MULTIPLE DRUG THERAPY 59 0.0782
28 PRE-EXISTING DISEASE 38 0.0782
29 PARTNER STRESS 72 0.0752
30 PROTRUSION TONGUE 43 0.0738
31 DYSKINESIA 2564 0.0630
32 FEAR 1693 0.0629
33 ANHEDONIA 1637 0.0622
34 METABOLIC DISORDER 329 0.0566
35 PHAEOCHROMOCYTOMA 34 0.0515
36 APLASTIC ANAEMIA 265 0.0507
37 NEUTROPENIC SEPSIS 360 0.0504
38 PARKINSONISM 447 0.0458
39 SYSTEMIC INFECTION 75 0.0452
40 NEPHROGENIC ANAEMIA 201 0.0433
41 HYPERPARATHYROIDISM SECONDARY 107 0.0427
42 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 40 0.0377
43 FEMALE GENITAL TRACT FISTULA 63 0.0369
44 MATERNAL EXPOSURE DURING DELIVERY 36 0.0363
45 SUBILEUS 74 0.0355
46 OCULOGYRIC CRISIS 76 0.0354
47 RESTLESS LEGS SYNDROME 616 0.0338
48 EMOTIONAL DISORDER 1032 0.0334
49 LONG QT SYNDROME 77 0.0321
50 FEBRILE NEUTROPENIA 2098 0.0316
51 ALVEOLITIS 42 0.0297
52 REBOUND ACID HYPERSECRETION 86 0.0284
53 ESCHERICHIA BACTERAEMIA 64 0.0272
54 RADICULOPATHY 71 0.0269
55 ESCHERICHIA TEST POSITIVE 32 0.0267
56 SEROTONIN SYNDROME 506 0.0263
57 TUMOUR PAIN 34 0.0258
58 PROCTITIS 71 0.0253
59 COLONIC POLYP 41 0.0248
60 DRUG CLEARANCE DECREASED 32 0.0245
61 GASTRIC POLYPS 54 0.0239
62 SECONDARY ADRENOCORTICAL INSUFFICIENCY 35 0.0232
63 IMPAIRED WORK ABILITY 483 0.0226
64 MENTAL DISORDER 971 0.0223
65 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
66 TORTICOLLIS 47 0.0221
67 RESPIRATORY ALKALOSIS 36 0.0221
68 NEUTROPENIC COLITIS 45 0.0217
69 ATELECTASIS 206 0.0213
70 APLASIA 41 0.0209
71 TORSADE DE POINTES 164 0.0209
72 CLONUS 56 0.0204
73 BLOOD CHOLESTEROL DECREASED 38 0.0204
74 BACTERIAL TEST POSITIVE 44 0.0197
75 END STAGE RENAL DISEASE 359 0.0197
76 PEPTIC ULCER 65 0.0196
77 NEUTROPHIL COUNT ABNORMAL 55 0.0194
78 LOSS OF EMPLOYMENT 58 0.0192
79 CHRONIC SINUSITIS 71 0.0189
80 CYTOKINE RELEASE SYNDROME 377 0.0188
81 IMPAIRED GASTRIC EMPTYING 255 0.0187
82 HYPERREFLEXIA 65 0.0186
83 BLOOD BICARBONATE DECREASED 35 0.0185
84 DIABETES INSIPIDUS 44 0.0183
85 TOXIC EPIDERMAL NECROLYSIS 276 0.0182
86 HYPOMAGNESAEMIA 252 0.0181
87 VITAMIN B12 DECREASED 52 0.0180
88 MUCOSAL INFLAMMATION 471 0.0180
89 NON-CARDIAC CHEST PAIN 55 0.0174
90 IMMUNE-MEDIATED HEPATITIS 35 0.0171
91 METHAEMOGLOBINAEMIA 39 0.0168
92 CLOSTRIDIUM TEST POSITIVE 37 0.0168
93 ELECTROCARDIOGRAM T WAVE INVERSION 37 0.0167
94 AORTIC ARTERIOSCLEROSIS 43 0.0167
95 DISTURBANCE IN SOCIAL BEHAVIOUR 39 0.0165
96 THERAPEUTIC AGENT TOXICITY 55 0.0165
97 HYPERPHOSPHATAEMIA 35 0.0163
98 HYPOKALAEMIA 748 0.0162
99 ABDOMINAL TENDERNESS 79 0.0159
100 EMOTIONAL DISTRESS 1905 0.0157
101 ATRIOVENTRICULAR BLOCK FIRST DEGREE 67 0.0154
102 UNEVALUABLE EVENT 1141 0.0151
103 LEFT VENTRICULAR DYSFUNCTION 101 0.0151
104 BLOOD MAGNESIUM DECREASED 130 0.0150
105 BLOOD PRESSURE DIASTOLIC ABNORMAL 38 0.0149
106 BRUXISM 80 0.0148
107 CACHEXIA 76 0.0148
108 BRADYKINESIA 87 0.0147
109 BLOOD CHLORIDE DECREASED 38 0.0147
110 BLOOD CREATININE DECREASED 46 0.0147
111 HYPOPHOSPHATAEMIA 107 0.0145
112 OESOPHAGITIS 153 0.0140
113 STAPHYLOCOCCAL SEPSIS 69 0.0140
114 ILEUS 173 0.0139
115 URINARY TRACT OBSTRUCTION 33 0.0139
116 RHINOVIRUS INFECTION 54 0.0139
117 BACTERAEMIA 161 0.0136
118 ANXIETY DISORDER 45 0.0134
119 NEUROLEPTIC MALIGNANT SYNDROME 159 0.0134
120 TRANSFUSION 140 0.0133
121 PATENT DUCTUS ARTERIOSUS 53 0.0133
122 MYOCLONUS 157 0.0132
123 STUPOR 42 0.0131
124 JAUNDICE CHOLESTATIC 46 0.0130
125 CLOSTRIDIUM DIFFICILE COLITIS 138 0.0130
126 INJURY 904 0.0128
127 ELECTROCARDIOGRAM QT PROLONGED 460 0.0128
128 AREFLEXIA 34 0.0127
129 HYPOALBUMINAEMIA 99 0.0127
130 HIATUS HERNIA 164 0.0127
131 STAPHYLOCOCCAL BACTERAEMIA 55 0.0126
132 ELECTROLYTE IMBALANCE 147 0.0126
133 POLYDIPSIA 50 0.0126
134 BLOOD CREATINE INCREASED 55 0.0124
135 DYSAESTHESIA 38 0.0124
136 CHRONIC KIDNEY DISEASE 942 0.0124
137 SWOLLEN TONGUE 387 0.0124
138 OXYGEN SATURATION ABNORMAL 35 0.0123
139 PROSTATE CANCER METASTATIC 41 0.0123
140 STRIDOR 36 0.0122
141 TREMOR 2008 0.0121
142 LOW BIRTH WEIGHT BABY 96 0.0121
143 DUODENITIS 37 0.0120
144 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 71 0.0120
145 PROTEIN TOTAL DECREASED 45 0.0119
146 ENTERITIS 76 0.0119
147 ORAL CANDIDIASIS 155 0.0118
148 NEUROLOGICAL SYMPTOM 67 0.0117
149 MIXED LIVER INJURY 35 0.0116
150 HYPONATRAEMIA 646 0.0115
151 MASTICATION DISORDER 35 0.0114
152 SPINAL OSTEOARTHRITIS 100 0.0114
153 BLOOD CULTURE POSITIVE 34 0.0113
154 ANXIETY 3230 0.0113
155 METASTASES TO SPINE 38 0.0113
156 MUSCLE RIGIDITY 133 0.0111
157 AMYLASE INCREASED 41 0.0111
158 HYDRONEPHROSIS 83 0.0111
159 TALIPES 34 0.0109
160 HEPATIC CYTOLYSIS 139 0.0109
161 IMMUNE-MEDIATED ENTEROCOLITIS 40 0.0109
162 TRISMUS 56 0.0108
163 BLOOD ALBUMIN DECREASED 86 0.0108
164 ENTEROCOLITIS 62 0.0107
165 TUMOUR LYSIS SYNDROME 94 0.0107
166 BRAIN DEATH 33 0.0107
167 SINUS TACHYCARDIA 150 0.0106
168 ODYNOPHAGIA 63 0.0105
169 ILEUS PARALYTIC 47 0.0105
170 BLOOD UREA INCREASED 176 0.0105
171 AUTOIMMUNE HAEMOLYTIC ANAEMIA 36 0.0105
172 GASTRITIS 276 0.0105
173 MOUTH ULCERATION 220 0.0104
174 NEUROPATHY PERIPHERAL 992 0.0104
175 HYPOXIA 366 0.0104
176 SNORING 39 0.0103
177 DIVERTICULUM INTESTINAL 45 0.0103
178 MUSCLE CONTRACTIONS INVOLUNTARY 36 0.0102
179 ACUTE KIDNEY INJURY 1563 0.0102
180 MALNUTRITION 114 0.0102
181 ACUTE PULMONARY OEDEMA 57 0.0101
182 BLOOD CREATININE ABNORMAL 35 0.0101
183 RASH MACULO-PAPULAR 225 0.0101
184 PREMATURE DELIVERY 160 0.0100
185 LEFT VENTRICULAR HYPERTROPHY 43 0.0100
186 HYPERLIPIDAEMIA 120 0.0100
187 FAECALOMA 55 0.0100
188 CEREBRAL ATROPHY 40 0.0100
189 OESOPHAGEAL CANDIDIASIS 40 0.0100
190 INTESTINAL ISCHAEMIA 55 0.0100
191 ARTERIOSCLEROSIS CORONARY ARTERY 66 0.0100
192 LIVE BIRTH 83 0.0099
193 HICCUPS 81 0.0099
194 CHOLECYSTITIS CHRONIC 66 0.0098
195 PREMATURE BABY 296 0.0098
196 HYPERCALCAEMIA 121 0.0098
197 GASTROENTERITIS 142 0.0097
198 EJECTION FRACTION DECREASED 151 0.0097
199 RENAL TUBULAR NECROSIS 95 0.0097
200 STRESS CARDIOMYOPATHY 56 0.0096
201 HYPERTONIA 55 0.0096
202 TUBULOINTERSTITIAL NEPHRITIS 179 0.0095
203 FOETAL GROWTH RESTRICTION 58 0.0095
204 TOXIC ENCEPHALOPATHY 48 0.0095
205 FOETAL DEATH 49 0.0094
206 THROMBOPHLEBITIS 33 0.0094
207 RESPIRATORY ACIDOSIS 37 0.0094
208 DRUG LEVEL ABOVE THERAPEUTIC 43 0.0094
209 NORMAL NEWBORN 51 0.0094
210 CHOLANGITIS 58 0.0093
211 BLOOD CALCIUM DECREASED 105 0.0093
212 UROSEPSIS 86 0.0093
213 DIABETIC NEUROPATHY 46 0.0093
214 AZOTAEMIA 37 0.0093
215 TONGUE DISORDER 67 0.0093
216 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 94 0.0091
217 RED CELL DISTRIBUTION WIDTH INCREASED 38 0.0091
218 HAEMATEMESIS 231 0.0091
219 ENTEROCOCCAL INFECTION 44 0.0091
220 HYPOVOLAEMIA 53 0.0090
221 BLOOD PHOSPHORUS DECREASED 33 0.0090
222 BLOOD THYROID STIMULATING HORMONE DECREASED 41 0.0090
223 PREMATURE LABOUR 51 0.0090
224 HYPERURICAEMIA 37 0.0090
225 PERFORMANCE STATUS DECREASED 42 0.0090
226 SEPTIC SHOCK 391 0.0090
227 RENAL FAILURE CHRONIC 69 0.0090
228 HYPOCALCAEMIA 169 0.0089
229 EYE MOVEMENT DISORDER 61 0.0089
230 NEUTROPHIL COUNT DECREASED 363 0.0089
231 VITAMIN B12 DEFICIENCY 36 0.0089
232 PNEUMONITIS 242 0.0089
233 OESOPHAGEAL ULCER 34 0.0088
234 SMALL INTESTINAL OBSTRUCTION 108 0.0088
235 RHINITIS ALLERGIC 39 0.0088
236 RENAL CYST 69 0.0087
237 TRICUSPID VALVE INCOMPETENCE 69 0.0087
238 INTERVERTEBRAL DISC DEGENERATION 80 0.0086
239 FACIAL PAIN 77 0.0086
240 UPPER GASTROINTESTINAL HAEMORRHAGE 145 0.0086
241 PNEUMONIA FUNGAL 34 0.0086
242 LUNG INFILTRATION 76 0.0086
243 DRUG INTERACTION 1365 0.0086
244 ATRIAL SEPTAL DEFECT 72 0.0086
245 PHYSICAL DISABILITY 38 0.0086
246 ADRENAL INSUFFICIENCY 104 0.0086
247 CHOLECYSTITIS 102 0.0086
248 VENTRICULAR FIBRILLATION 95 0.0085
249 CYTOMEGALOVIRUS VIRAEMIA 38 0.0085
250 PANCYTOPENIA 477 0.0085
251 TACHYPNOEA 116 0.0085
252 MUSCULOSKELETAL CHEST PAIN 132 0.0085
253 ATAXIA 101 0.0085
254 FEBRILE BONE MARROW APLASIA 36 0.0085
255 MUSCLE TWITCHING 195 0.0085
256 BLOOD ALKALINE PHOSPHATASE INCREASED 209 0.0084
257 STEVENS-JOHNSON SYNDROME 187 0.0084
258 HYPERBILIRUBINAEMIA 87 0.0084
259 SINUS BRADYCARDIA 81 0.0084
260 INTESTINAL PERFORATION 94 0.0084
261 ARTERIOSPASM CORONARY 33 0.0082
262 PERIPHERAL SENSORY NEUROPATHY 48 0.0082
263 LUNG INFECTION 127 0.0082
264 PLEURAL EFFUSION 495 0.0081
265 ANGIOEDEMA 355 0.0080
266 DEHYDRATION 1066 0.0080
267 RENAL FAILURE ACUTE 339 0.0080
268 CHOLECYSTITIS ACUTE 45 0.0079
269 GASTRITIS EROSIVE 37 0.0079
270 COLITIS 300 0.0079
271 TENSION HEADACHE 34 0.0079
272 VAGINAL DISCHARGE 80 0.0079
273 ELECTROCARDIOGRAM ABNORMAL 62 0.0079
274 ENCEPHALOPATHY 194 0.0079
275 PATHOLOGICAL FRACTURE 40 0.0079
276 MITRAL VALVE INCOMPETENCE 89 0.0079
277 ISCHAEMIA 36 0.0078
278 CARDIOMEGALY 96 0.0078
279 URINARY RETENTION 260 0.0078
280 COVID-19 PNEUMONIA 92 0.0078
281 URINE OUTPUT DECREASED 68 0.0078
282 DIVERTICULUM 55 0.0077
283 PAIN 4747 0.0077
284 NEUTROPHIL COUNT INCREASED 79 0.0077
285 HYPERPROLACTINAEMIA 50 0.0077
286 BREATH SOUNDS ABNORMAL 38 0.0077
287 HEPATIC FAILURE 232 0.0077
288 RENAL FAILURE 1011 0.0076
289 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 57 0.0076
290 HYPOPHAGIA 194 0.0076
291 DISABILITY 150 0.0076
292 MATERNAL DRUGS AFFECTING FOETUS 58 0.0076
293 RENAL CELL CARCINOMA 37 0.0076
294 ASCITES 222 0.0075
295 ESCHERICHIA URINARY TRACT INFECTION 32 0.0075
296 SUPRAVENTRICULAR TACHYCARDIA 72 0.0075
297 RENAL INJURY 223 0.0075
298 DECUBITUS ULCER 61 0.0075
299 HYPERKALAEMIA 262 0.0075
300 HEPATITIS CHOLESTATIC 45 0.0075
301 MYOCARDIAL ISCHAEMIA 85 0.0075
302 GAMMA-GLUTAMYLTRANSFERASE INCREASED 165 0.0074
303 BLOOD BILIRUBIN INCREASED 201 0.0074
304 DELIRIUM 258 0.0074
305 SEPSIS 829 0.0074
306 RESPIRATORY DEPRESSION 91 0.0074
307 SPINAL COLUMN STENOSIS 35 0.0074
308 LOWER RESPIRATORY TRACT INFECTION 337 0.0074
309 DIABETES MELLITUS INADEQUATE CONTROL 131 0.0074
310 VENTRICULAR SEPTAL DEFECT 42 0.0073
311 FAILURE TO THRIVE 38 0.0073
312 METABOLIC ACIDOSIS 234 0.0073
313 PROCTALGIA 47 0.0073
314 THROMBOCYTOPENIA 817 0.0073
315 BLOOD PRESSURE SYSTOLIC DECREASED 33 0.0072
316 OLIGURIA 45 0.0072
317 OSTEOPENIA 110 0.0072
318 ENCEPHALITIS 50 0.0072
319 CEREBRAL ISCHAEMIA 37 0.0072
320 MULTIPLE ORGAN DYSFUNCTION SYNDROME 203 0.0072
321 ANAEMIA 1365 0.0071
322 GENERAL PHYSICAL HEALTH DETERIORATION 828 0.0071
323 LEUKOCYTOSIS 129 0.0071
324 RESPIRATORY SYNCYTIAL VIRUS INFECTION 62 0.0071
325 MULTI-ORGAN FAILURE 123 0.0071
326 VOMITING 3322 0.0071
327 PYELONEPHRITIS 61 0.0070
328 NEUTROPENIA 957 0.0070
329 PROTHROMBIN TIME PROLONGED 42 0.0070
330 ACUTE CORONARY SYNDROME 58 0.0070
331 PARAESTHESIA ORAL 101 0.0070
332 PERIPHERAL VASCULAR DISORDER 36 0.0070
333 BRAIN OEDEMA 88 0.0070
334 NEPHROPATHY 65 0.0070
335 RESTLESSNESS 254 0.0069
336 CONSTIPATION 1508 0.0069
337 OBESITY 110 0.0069
338 SPINAL COMPRESSION FRACTURE 57 0.0069
339 CIRCULATORY COLLAPSE 117 0.0069
340 SKIN INFECTION 77 0.0069
341 GASTROINTESTINAL SOUNDS ABNORMAL 34 0.0069
342 METASTASES TO LIVER 120 0.0068
343 PNEUMONIA ASPIRATION 170 0.0068
344 LYMPHOCYTE COUNT DECREASED 120 0.0068
345 ORTHOSTATIC HYPOTENSION 118 0.0068
346 PANCREATITIS ACUTE 152 0.0068
347 ASPIRATION 74 0.0067
348 DYSPHONIA 394 0.0067
349 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 34 0.0067
350 SUDDEN DEATH 71 0.0067
351 GENERALISED OEDEMA 83 0.0067
352 POLYNEUROPATHY 80 0.0067
353 RESPIRATORY FAILURE 487 0.0067
354 METASTASES TO LYMPH NODES 45 0.0067
355 BLOOD CREATININE INCREASED 435 0.0067
356 RESPIRATORY RATE INCREASED 59 0.0066
357 APPETITE DISORDER 44 0.0066
358 LARGE INTESTINE PERFORATION 46 0.0066
359 ACUTE RESPIRATORY FAILURE 127 0.0066
360 ABDOMINAL PAIN 1519 0.0065
361 KLEBSIELLA INFECTION 33 0.0065
362 ANAL ABSCESS 35 0.0065
363 BLOOD SODIUM DECREASED 122 0.0065
364 TACHYCARDIA 575 0.0065
365 FOETAL EXPOSURE DURING PREGNANCY 526 0.0065
366 CARDIAC FAILURE ACUTE 43 0.0064
367 HYPOGLYCAEMIA 313 0.0064
368 PHLEBITIS 33 0.0064
369 SPUTUM DISCOLOURED 61 0.0064
370 HAEMORRHOIDS 125 0.0064
371 LIPASE INCREASED 49 0.0064
372 HYPERGLYCAEMIA 233 0.0064
373 PYREXIA 2210 0.0064
374 COLITIS ISCHAEMIC 43 0.0064
375 DEVICE RELATED INFECTION 98 0.0064
376 BLEPHAROSPASM 40 0.0063
377 CANDIDA INFECTION 107 0.0063
378 SWELLING FACE 412 0.0063
379 CHOLESTASIS 121 0.0063
380 PSEUDOMONAS INFECTION 54 0.0063
381 LIVER FUNCTION TEST ABNORMAL 183 0.0063
382 HYDROCEPHALUS 34 0.0062
383 ALANINE AMINOTRANSFERASE INCREASED 383 0.0062
384 NEPHROPATHY TOXIC 70 0.0062
385 C-REACTIVE PROTEIN INCREASED 226 0.0062
386 BENIGN PROSTATIC HYPERPLASIA 32 0.0062
387 FLANK PAIN 58 0.0062
388 PERONEAL NERVE PALSY 35 0.0062
389 GINGIVAL PAIN 49 0.0062
390 ORAL DISORDER 45 0.0061
391 RIGHT VENTRICULAR FAILURE 43 0.0061
392 PETECHIAE 64 0.0061
393 ANOREXIA 79 0.0061
394 HYPOTONIA 61 0.0061
395 CATATONIA 32 0.0061
396 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 58 0.0061
397 PNEUMOTHORAX 96 0.0060
398 ACUTE RESPIRATORY DISTRESS SYNDROME 107 0.0060
399 PULMONARY EMBOLISM 574 0.0060
400 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
401 HAEMOLYTIC ANAEMIA 54 0.0060
402 MYOSITIS 54 0.0060
403 HEPATITIS ACUTE 39 0.0060
404 VISUAL IMPAIRMENT 743 0.0060
405 MOTOR DYSFUNCTION 61 0.0060
406 JAUNDICE 161 0.0060
407 BODY TEMPERATURE INCREASED 122 0.0060
408 GRAND MAL CONVULSION 55 0.0060
409 DRUG TOXICITY 81 0.0059
410 NEUROTOXICITY 104 0.0059
411 CARDIAC ARREST 489 0.0059
412 BONE MARROW FAILURE 120 0.0059
413 HAEMATOCRIT DECREASED 117 0.0059
414 MACULAR DEGENERATION 70 0.0059
415 METASTASES TO BONE 96 0.0058
416 INITIAL INSOMNIA 60 0.0058
417 FLUID OVERLOAD 85 0.0058
418 HEPATOTOXICITY 130 0.0058
419 CHOLELITHIASIS 191 0.0058
420 HEPATITIS 149 0.0058
421 MYOPATHY 50 0.0058
422 OSTEOPOROSIS 238 0.0058
423 DECREASED APPETITE 1343 0.0058
424 PNEUMOCYSTIS JIROVECII PNEUMONIA 58 0.0058
425 ORAL PAIN 129 0.0058
426 ACIDOSIS 44 0.0058
427 AUTOIMMUNE HEPATITIS 40 0.0057
428 MELAENA 126 0.0057
429 ASPARTATE AMINOTRANSFERASE INCREASED 304 0.0057
430 DYSPHAGIA 542 0.0057
431 HEPATIC ENCEPHALOPATHY 53 0.0057
432 DUODENAL ULCER 40 0.0057
433 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 44 0.0057
434 LEUKOPENIA 283 0.0057
435 PRODUCTIVE COUGH 270 0.0057
436 VENTRICULAR TACHYCARDIA 93 0.0056
437 DEPRESSED LEVEL OF CONSCIOUSNESS 222 0.0056
438 WALKING AID USER 37 0.0056
439 CYANOSIS 88 0.0056
440 UNRESPONSIVE TO STIMULI 144 0.0056
441 HYPOTENSION 1117 0.0056
442 GENERALISED TONIC-CLONIC SEIZURE 92 0.0056
443 SLEEP APNOEA SYNDROME 106 0.0055
444 RECTAL HAEMORRHAGE 237 0.0055
445 HAEMODYNAMIC INSTABILITY 42 0.0055
446 PRESYNCOPE 134 0.0055
447 CONCOMITANT DISEASE AGGRAVATED 34 0.0055
448 ACUTE MYOCARDIAL INFARCTION 162 0.0055
449 POISONING 69 0.0055
450 ACUTE HEPATIC FAILURE 75 0.0055
451 INCONTINENCE 58 0.0055
452 DYSARTHRIA 205 0.0054
453 HEPATIC STEATOSIS 101 0.0054
454 BLOOD POTASSIUM INCREASED 88 0.0054
455 LOWER GASTROINTESTINAL HAEMORRHAGE 40 0.0054
456 SECOND PRIMARY MALIGNANCY 45 0.0054
457 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 126 0.0054
458 MALIGNANT NEOPLASM PROGRESSION 553 0.0054
459 SALIVARY HYPERSECRETION 54 0.0054
460 TERMINAL STATE 36 0.0054
461 HYPERTHERMIA 41 0.0054
462 BLOOD LACTATE DEHYDROGENASE INCREASED 85 0.0054
463 GROIN PAIN 47 0.0053
464 GASTROOESOPHAGEAL REFLUX DISEASE 430 0.0053
465 CELLULITIS 269 0.0053
466 BLADDER DISORDER 53 0.0053
467 MATERNAL EXPOSURE DURING PREGNANCY 475 0.0053
468 LETHARGY 306 0.0053
469 PURPURA 47 0.0053
470 EOSINOPHILIA 93 0.0053
471 SUBARACHNOID HAEMORRHAGE 54 0.0053
472 DEEP VEIN THROMBOSIS 344 0.0053
473 NAUSEA 4165 0.0053
474 TROPONIN INCREASED 40 0.0053
475 MENTAL STATUS CHANGES 146 0.0053
476 INFUSION RELATED REACTION 348 0.0052
477 PULMONARY HYPERTENSION 109 0.0052
478 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 287 0.0052
479 MUSCLE ATROPHY 66 0.0052
480 DISORIENTATION 206 0.0052
481 ANAPHYLACTIC REACTION 287 0.0052
482 DIFFUSE LARGE B-CELL LYMPHOMA 40 0.0052
483 EXPOSURE DURING PREGNANCY 322 0.0052
484 TRANSAMINASES INCREASED 115 0.0052
485 FACIAL PARALYSIS 44 0.0052
486 DYSGRAPHIA 34 0.0052
487 CONFUSIONAL STATE 834 0.0052
488 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
489 STATUS EPILEPTICUS 58 0.0051
490 WHITE BLOOD CELL COUNT INCREASED 197 0.0051
491 PAIN IN JAW 145 0.0051
492 DEMENTIA 143 0.0051
493 ATRIAL FIBRILLATION 498 0.0051
494 GASTRIC ULCER 97 0.0051
495 MENINGITIS 34 0.0051
496 POST-TRAUMATIC STRESS DISORDER 34 0.0051
497 EMBOLISM 42 0.0051
498 REFUSAL OF TREATMENT BY PATIENT 33 0.0050
499 STOMATITIS 306 0.0050
500 APHASIA 152 0.0050
501 HAEMODIALYSIS 42 0.0050
502 SPEECH DISORDER 262 0.0050
503 DYSURIA 184 0.0050
504 HAEMOGLOBIN DECREASED 513 0.0050
505 PULMONARY OEDEMA 223 0.0050
506 CARDIO-RESPIRATORY ARREST 208 0.0050
507 RESPIRATORY DISTRESS 137 0.0050
508 METASTASES TO CENTRAL NERVOUS SYSTEM 64 0.0050
509 BLOOD POTASSIUM DECREASED 149 0.0050
510 LYMPHOPENIA 70 0.0049
511 HYPOTHYROIDISM 158 0.0049
512 DEPRESSION 1123 0.0049
513 AGITATION 362 0.0049
514 DROOLING 34 0.0049
515 DIARRHOEA HAEMORRHAGIC 46 0.0049
516 RENAL IMPAIRMENT 413 0.0049
517 PLATELET COUNT DECREASED 522 0.0049
518 AGRANULOCYTOSIS 91 0.0049
519 ALTERED STATE OF CONSCIOUSNESS 106 0.0049
520 ARTERIOSCLEROSIS 46 0.0049
521 HAEMATURIA 167 0.0049
522 HYPERCHOLESTEROLAEMIA 47 0.0049
523 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 43 0.0049
524 PNEUMONIA 1570 0.0048
525 CORONARY ARTERY DISEASE 146 0.0048
526 BRADYCARDIA 255 0.0048
527 HEPATOMEGALY 47 0.0048
528 PERICARDIAL EFFUSION 110 0.0048
529 PARANOIA 82 0.0048
530 EATING DISORDER 101 0.0047
531 ESCHERICHIA INFECTION 39 0.0047
532 DYSPNOEA EXERTIONAL 178 0.0047
533 VASCULITIS 55 0.0047
534 TOOTH ABSCESS 48 0.0047
535 ABDOMINAL DISTENSION 489 0.0047
536 CARDIOGENIC SHOCK 67 0.0047
537 IRON DEFICIENCY ANAEMIA 43 0.0047
538 ANURIA 40 0.0046
539 INTESTINAL OBSTRUCTION 175 0.0046
540 MYELODYSPLASTIC SYNDROME 67 0.0046
541 DYSPEPSIA 455 0.0046
542 SYNCOPE 462 0.0046
543 RESPIRATORY TRACT INFECTION 120 0.0046
544 ASTHENIA 1730 0.0046
545 LACTIC ACIDOSIS 149 0.0046
546 TOXICITY TO VARIOUS AGENTS 775 0.0046
547 PERITONITIS 95 0.0046
548 SEDATION 120 0.0046
549 INTERVERTEBRAL DISC PROTRUSION 100 0.0046
550 OEDEMA PERIPHERAL 557 0.0046
551 URINARY TRACT INFECTION 779 0.0046
552 DERMATITIS BULLOUS 33 0.0046
553 GLOMERULAR FILTRATION RATE DECREASED 56 0.0046
554 BRONCHOSPASM 65 0.0046
555 CHOLECYSTECTOMY 52 0.0045
556 EAR PAIN 88 0.0045
557 DISEASE PROGRESSION 534 0.0045
558 ATRIAL FLUTTER 36 0.0045
559 CARDIAC MURMUR 39 0.0045
560 SUICIDAL IDEATION 410 0.0045
561 GASTROINTESTINAL INFLAMMATION 35 0.0045
562 CARDIOMYOPATHY 66 0.0045
563 HEMIPARESIS 75 0.0044
564 RIB FRACTURE 91 0.0044
565 METASTASES TO LUNG 51 0.0044
566 VITAMIN D DEFICIENCY 43 0.0044
567 DIARRHOEA 2843 0.0044
568 ABSCESS 70 0.0044
569 RHABDOMYOLYSIS 182 0.0044
570 MIOSIS 35 0.0044
571 BLOOD PRESSURE SYSTOLIC INCREASED 85 0.0044
572 DRUG-INDUCED LIVER INJURY 136 0.0043
573 PULMONARY CONGESTION 57 0.0043
574 BACTERIAL INFECTION 80 0.0043
575 BONE DISORDER 78 0.0043
576 CYTOMEGALOVIRUS INFECTION 71 0.0043
577 SPLENOMEGALY 50 0.0043
578 GALLBLADDER DISORDER 76 0.0043
579 NEOPLASM PROGRESSION 148 0.0043
580 DENTAL CARIES 47 0.0042
581 STAPHYLOCOCCAL INFECTION 140 0.0042
582 VENTRICULAR EXTRASYSTOLES 44 0.0042
583 LACRIMATION INCREASED 128 0.0042
584 NAIL DISORDER 37 0.0042
585 ANAL INCONTINENCE 38 0.0042
586 SENSORY LOSS 34 0.0042
587 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220 0.0042
588 MYDRIASIS 54 0.0042
589 CAESAREAN SECTION 49 0.0042
590 OSTEOARTHRITIS 178 0.0042
591 EAR DISCOMFORT 43 0.0042
592 OXYGEN SATURATION DECREASED 235 0.0042
593 ERYTHEMA MULTIFORME 39 0.0042
594 PANCREATITIS 221 0.0042
595 HEPATOCELLULAR INJURY 59 0.0042
596 UPPER RESPIRATORY TRACT INFECTION 192 0.0042
597 POLYURIA 34 0.0041
598 PNEUMONIA BACTERIAL 38 0.0041
599 INTERSTITIAL LUNG DISEASE 199 0.0041
600 DRUG LEVEL INCREASED 68 0.0041
601 THROMBOTIC MICROANGIOPATHY 40 0.0041
602 CYTOPENIA 50 0.0041
603 FREQUENT BOWEL MOVEMENTS 110 0.0041
604 PLATELET COUNT INCREASED 53 0.0041
605 EMPHYSEMA 41 0.0041
606 BODY TEMPERATURE DECREASED 40 0.0041
607 CONVULSION 232 0.0041
608 SUBDURAL HAEMATOMA 58 0.0040
609 COGNITIVE DISORDER 189 0.0040
610 CHROMATURIA 91 0.0040
611 URINARY INCONTINENCE 118 0.0040
612 FEELING COLD 110 0.0039
613 SKIN ULCER 102 0.0039
614 HYPERTENSION 835 0.0039
615 PALLOR 107 0.0039
616 MUSCLE STRAIN 34 0.0039
617 ERUCTATION 76 0.0039
618 FACE OEDEMA 66 0.0039
619 HYPERHIDROSIS 504 0.0039
620 CHEST PAIN 722 0.0039
621 GASTROINTESTINAL DISORDER 349 0.0039
622 OEDEMA 211 0.0039
623 DIALYSIS 55 0.0039
624 HAEMOPTYSIS 108 0.0039
625 PHARYNGITIS 48 0.0039
626 MEDICATION ERROR 215 0.0039
627 BACK PAIN 898 0.0039
628 HYPERTENSIVE CRISIS 43 0.0039
629 FEEDING DISORDER 78 0.0038
630 LIMB DISCOMFORT 119 0.0038
631 BLOOD PRESSURE DECREASED 254 0.0038
632 DYSPNOEA 2154 0.0038
633 CARDIAC FAILURE 305 0.0038
634 PERIPHERAL COLDNESS 52 0.0038
635 ACUTE MYELOID LEUKAEMIA 59 0.0038
636 SHOCK 87 0.0038
637 FAECES DISCOLOURED 82 0.0038
638 HYPOTHERMIA 38 0.0037
639 HAEMATOCHEZIA 207 0.0037
640 RED BLOOD CELL COUNT DECREASED 107 0.0037
641 NEURALGIA 91 0.0037
642 ARRHYTHMIA 177 0.0037
643 WEIGHT DECREASED 1038 0.0037
644 NOCTURIA 45 0.0037
645 OBSTRUCTIVE AIRWAYS DISORDER 41 0.0037
646 HEPATIC FUNCTION ABNORMAL 136 0.0036
647 EPISTAXIS 272 0.0036
648 PULMONARY MASS 54 0.0036
649 DRY MOUTH 294 0.0036
650 TRANSIENT ISCHAEMIC ATTACK 122 0.0036
651 OSTEOMYELITIS 65 0.0036
652 DIABETIC KETOACIDOSIS 86 0.0036
653 MYOCARDITIS 41 0.0036
654 COLD SWEAT 63 0.0036
655 RETCHING 76 0.0036
656 ABDOMINAL PAIN LOWER 90 0.0036
657 ABDOMINAL PAIN UPPER 731 0.0035
658 TENDERNESS 37 0.0035
659 GASTROINTESTINAL PAIN 39 0.0035
660 COAGULOPATHY 59 0.0035
661 THIRST 63 0.0035
662 PROTEINURIA 67 0.0035
663 IRRITABLE BOWEL SYNDROME 75 0.0035
664 PROCEDURAL PAIN 97 0.0035
665 SPINAL FRACTURE 70 0.0035
666 TOXIC SKIN ERUPTION 35 0.0035
667 MUSCULAR WEAKNESS 394 0.0035
668 WHITE BLOOD CELL COUNT DECREASED 375 0.0035
669 HALLUCINATION 260 0.0034
670 NO THERAPEUTIC RESPONSE 42 0.0034
671 CLOSTRIDIUM DIFFICILE INFECTION 75 0.0034
672 CARPAL TUNNEL SYNDROME 48 0.0034
673 MUSCULOSKELETAL PAIN 179 0.0034
674 DEPRESSED MOOD 180 0.0034
675 SKIN LESION 93 0.0034
676 PULMONARY FIBROSIS 65 0.0034
677 DRUG INTOLERANCE 327 0.0034
678 INTERNATIONAL NORMALISED RATIO INCREASED 96 0.0034
679 HALLUCINATION, VISUAL 71 0.0034
680 TASTE DISORDER 68 0.0033
681 CHILLS 389 0.0033
682 NODULE 43 0.0033
683 MALIGNANT MELANOMA 44 0.0033
684 PARALYSIS 47 0.0033
685 POST PROCEDURAL COMPLICATION 63 0.0033
686 LIP SWELLING 109 0.0033
687 HYPERSENSITIVITY 607 0.0033
688 BREAST CANCER METASTATIC 35 0.0033
689 GASTROINTESTINAL HAEMORRHAGE 272 0.0033
690 VERTIGO 198 0.0032
691 LOSS OF CONSCIOUSNESS 415 0.0032
692 OSTEONECROSIS OF JAW 80 0.0032
693 OROPHARYNGEAL PAIN 299 0.0032
694 JOINT DISLOCATION 34 0.0032
695 BALANCE DISORDER 278 0.0032
696 GASTROENTERITIS VIRAL 58 0.0032
697 WOUND INFECTION 35 0.0032
698 LYMPHADENOPATHY 113 0.0032
699 BRAIN INJURY 32 0.0032
700 HYPERTHYROIDISM 46 0.0032
701 PANIC ATTACK 115 0.0032
702 MICTURITION URGENCY 36 0.0031
703 MUSCLE TIGHTNESS 51 0.0031
704 CONDITION AGGRAVATED 957 0.0031
705 SOMNOLENCE 633 0.0031
706 LIVER FUNCTION TEST INCREASED 67 0.0031
707 RESPIRATORY ARREST 86 0.0031
708 RENAL PAIN 33 0.0031
709 DRUG ERUPTION 55 0.0031
710 FEMUR FRACTURE 96 0.0031
711 FIBROMYALGIA 75 0.0031
712 ULCER 49 0.0031
713 CYSTITIS 98 0.0031
714 BRAIN FOG 48 0.0031
715 FATIGUE 2382 0.0031
716 HAEMATOMA 79 0.0030
717 MULTIPLE FRACTURES 50 0.0030
718 RESPIRATORY DISORDER 91 0.0030
719 DIPLOPIA 79 0.0030
720 TYPE 2 DIABETES MELLITUS 102 0.0030
721 ABNORMAL BEHAVIOUR 120 0.0030
722 ISCHAEMIC STROKE 54 0.0030
723 POOR QUALITY SLEEP 65 0.0030
724 HAEMORRHAGE INTRACRANIAL 45 0.0030
725 BLISTER 169 0.0030
726 POST PROCEDURAL HAEMORRHAGE 35 0.0030
727 BLOOD URINE PRESENT 57 0.0030
728 FALL 996 0.0030
729 CEREBRAL INFARCTION 73 0.0030
730 PERICARDITIS 50 0.0030
731 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 51 0.0030
732 ORAL DISCOMFORT 41 0.0029
733 CHEST DISCOMFORT 300 0.0029
734 PHOTOPHOBIA 55 0.0029
735 COUGH 813 0.0029
736 PULMONARY ARTERIAL HYPERTENSION 42 0.0029
737 COMA 138 0.0029
738 INFECTION 418 0.0029
739 HEPATIC CIRRHOSIS 54 0.0029
740 SCAR 49 0.0029
741 GINGIVAL BLEEDING 39 0.0029
742 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 137 0.0028
743 FUNGAL INFECTION 95 0.0028
744 SEIZURE 329 0.0028
745 HEAD INJURY 90 0.0028
746 TREATMENT NONCOMPLIANCE 155 0.0028
747 ANGINA PECTORIS 81 0.0028
748 HYPOAESTHESIA 423 0.0028
749 BONE PAIN 165 0.0028
750 SKIN FISSURES 55 0.0028
751 MOBILITY DECREASED 202 0.0028
752 NECK PAIN 157 0.0028
753 MIGRAINE 268 0.0028
754 CONJUNCTIVITIS 52 0.0028
755 BRONCHITIS 207 0.0028
756 CEREBRAL HAEMORRHAGE 100 0.0028
757 MASS 39 0.0028
758 THERAPY NON-RESPONDER 125 0.0028
759 BLOOD TEST ABNORMAL 39 0.0028
760 PRODUCT PRESCRIBING ERROR 66 0.0028
761 GLOSSODYNIA 62 0.0028
762 ACCIDENT 33 0.0028
763 CARDIAC FAILURE CONGESTIVE 221 0.0027
764 EPILEPSY 84 0.0027
765 MALAISE 1205 0.0027
766 TOOTH INFECTION 36 0.0027
767 MUSCLE SPASMS 500 0.0027
768 CHOKING 53 0.0027
769 ANKLE FRACTURE 42 0.0027
770 TENDONITIS 42 0.0027
771 BLOOD PRESSURE FLUCTUATION 65 0.0027
772 HEART RATE INCREASED 268 0.0027
773 DIABETES MELLITUS 206 0.0027
774 TINNITUS 124 0.0027
775 CENTRAL NERVOUS SYSTEM LESION 37 0.0027
776 BASAL CELL CARCINOMA 42 0.0027
777 DIZZINESS 1341 0.0027
778 MUSCLE SPASTICITY 33 0.0027
779 FLATULENCE 152 0.0027
780 GOUT 48 0.0027
781 DERMATITIS 56 0.0027
782 DIVERTICULITIS 74 0.0027
783 LOCALISED INFECTION 64 0.0026
784 DRUG EXPOSURE DURING PREGNANCY 90 0.0026
785 PELVIC PAIN 48 0.0026
786 HEADACHE 1656 0.0026
787 WHEEZING 156 0.0026
788 MUSCULOSKELETAL DISCOMFORT 45 0.0026
789 PALPITATIONS 306 0.0026
790 GAIT INABILITY 87 0.0026
791 PSYCHOMOTOR HYPERACTIVITY 43 0.0026
792 OFF LABEL USE 2260 0.0026
793 PARAESTHESIA 402 0.0026
794 CONTUSION 244 0.0025
795 PRODUCT USE IN UNAPPROVED INDICATION 628 0.0025
796 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65 0.0025
797 DRUG ABUSE 210 0.0025
798 AMNESIA 164 0.0025
799 NIGHT SWEATS 81 0.0025
800 OVERDOSE 540 0.0025
801 LIVER DISORDER 111 0.0025
802 FLUSHING 254 0.0025
803 BLOOD TRIGLYCERIDES INCREASED 44 0.0025
804 FOOT FRACTURE 47 0.0025
805 CONTRAINDICATED PRODUCT ADMINISTERED 75 0.0025
806 DISTURBANCE IN ATTENTION 133 0.0025
807 NEPHROLITHIASIS 112 0.0024
808 GAIT DISTURBANCE 462 0.0024
809 BLOOD CREATINE PHOSPHOKINASE INCREASED 69 0.0024
810 ABASIA 59 0.0024
811 TOOTHACHE 43 0.0024
812 COORDINATION ABNORMAL 33 0.0024
813 FEELING HOT 145 0.0024
814 POLLAKIURIA 98 0.0023
815 COLON CANCER 35 0.0023
816 MUSCULOSKELETAL STIFFNESS 205 0.0023
817 INSOMNIA 622 0.0023
818 SEASONAL ALLERGY 33 0.0023
819 BLOOD GLUCOSE ABNORMAL 43 0.0023
820 LIVER INJURY 57 0.0023
821 HYPOAESTHESIA ORAL 35 0.0023
822 PAIN IN EXTREMITY 681 0.0023
823 PLASMA CELL MYELOMA 90 0.0023
824 SENSORY DISTURBANCE 37 0.0023
825 IMPAIRED QUALITY OF LIFE 33 0.0023
826 INTENTIONAL PRODUCT USE ISSUE 201 0.0023
827 KIDNEY INFECTION 45 0.0023
828 EYE PRURITUS 77 0.0023
829 JOINT STIFFNESS 60 0.0023
830 MYELOSUPPRESSION 82 0.0023
831 ALOPECIA 445 0.0023
832 APATHY 33 0.0023
833 BLINDNESS 92 0.0023
834 FEELING JITTERY 43 0.0023
835 WOUND 63 0.0023
836 ANAPHYLACTIC SHOCK 58 0.0022
837 ERYTHEMA 462 0.0022
838 HERNIA 43 0.0022
839 RASH ERYTHEMATOUS 106 0.0022
840 ACCIDENTAL OVERDOSE 80 0.0022
841 NERVOUSNESS 113 0.0022
842 RASH GENERALISED 56 0.0022
843 ILL-DEFINED DISORDER 131 0.0022
844 CEREBROVASCULAR ACCIDENT 364 0.0021
845 COMPLETED SUICIDE 179 0.0021
846 MENTAL IMPAIRMENT 52 0.0021
847 MIDDLE INSOMNIA 40 0.0021
848 PSYCHOTIC DISORDER 63 0.0021
849 SCIATICA 34 0.0021
850 GASTRIC DISORDER 73 0.0021
851 COLITIS ULCERATIVE 95 0.0021
852 INCORRECT PRODUCT ADMINISTRATION DURATION 46 0.0021
853 SLEEP DISORDER 149 0.0021
854 INTENTIONAL OVERDOSE 134 0.0021
855 PERIPHERAL SWELLING 321 0.0021
856 DISCOMFORT 127 0.0021
857 DYSGEUSIA 154 0.0021
858 BLOOD PRESSURE INCREASED 316 0.0021
859 LUNG DISORDER 101 0.0021
860 RENAL DISORDER 96 0.0021
861 RASH 896 0.0021
862 RASH PRURITIC 111 0.0020
863 PRODUCT ADMINISTRATION ERROR 41 0.0020
864 HIP FRACTURE 65 0.0020
865 SKIN DISCOLOURATION 92 0.0020
866 SINUSITIS 205 0.0020
867 THROAT TIGHTNESS 54 0.0020
868 INFLAMMATION 103 0.0020
869 PRURITUS GENERALISED 43 0.0020
870 HYPERSOMNIA 57 0.0020
871 ARTHRITIS 156 0.0020
872 CATARACT 117 0.0020
873 VIRAL INFECTION 65 0.0020
874 ORAL HERPES 38 0.0019
875 RASH MACULAR 68 0.0019
876 ARTHRALGIA 806 0.0019
877 TOOTH LOSS 40 0.0019
878 HEPATIC ENZYME INCREASED 131 0.0019
879 MYALGIA 323 0.0019
880 IMPAIRED HEALING 61 0.0019
881 RHINORRHOEA 120 0.0019
882 ABDOMINAL DISCOMFORT 310 0.0018
883 MYOCARDIAL INFARCTION 322 0.0018
884 FULL BLOOD COUNT DECREASED 37 0.0018
885 VISION BLURRED 248 0.0018
886 INCREASED APPETITE 34 0.0018
887 LOWER LIMB FRACTURE 34 0.0018
888 LIMB INJURY 48 0.0018
889 HEART RATE DECREASED 62 0.0018
890 ASTHMA 199 0.0018
891 THROMBOSIS 141 0.0018
892 HOT FLUSH 132 0.0017
893 INFLUENZA 195 0.0017
894 SWELLING 163 0.0017
895 RASH PAPULAR 39 0.0017
896 JOINT INJURY 37 0.0017
897 ARTHROPATHY 96 0.0017
898 DRUG PRESCRIBING ERROR 33 0.0017
899 SUICIDE ATTEMPT 104 0.0017
900 GLAUCOMA 33 0.0017
901 PRURITUS 647 0.0017
902 MEMORY IMPAIRMENT 231 0.0017
903 INTENTIONAL DRUG MISUSE 35 0.0017
904 PAIN OF SKIN 45 0.0017
905 HERPES ZOSTER 96 0.0017
906 FLUID RETENTION 84 0.0016
907 NEOPLASM MALIGNANT 110 0.0016
908 CARDIOVASCULAR DISORDER 41 0.0016
909 BLOOD PRESSURE ABNORMAL 32 0.0016
910 BLOOD CHOLESTEROL INCREASED 74 0.0016
911 GASTRIC CANCER 40 0.0016
912 AGEUSIA 39 0.0016
913 SKIN DISORDER 52 0.0016
914 DRY SKIN 206 0.0015
915 EAR INFECTION 41 0.0015
916 CARDIAC DISORDER 144 0.0015
917 BONE DENSITY DECREASED 48 0.0015
918 DEATH 1280 0.0015
919 ERECTILE DYSFUNCTION 38 0.0015
920 SKIN EXFOLIATION 124 0.0015
921 HAEMORRHAGE 153 0.0015
922 HEART RATE IRREGULAR 33 0.0015
923 CRYING 53 0.0015
924 DEAFNESS 38 0.0015
925 BURNING SENSATION 101 0.0014
926 EYE DISORDER 47 0.0014
927 AGGRESSION 71 0.0014
928 BLOOD GLUCOSE INCREASED 267 0.0014
929 BLOOD GLUCOSE DECREASED 68 0.0014
930 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 253 0.0014
931 JOINT SWELLING 169 0.0014
932 ECZEMA 73 0.0014
933 MOOD ALTERED 38 0.0014
934 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99 0.0014
935 NIGHTMARE 48 0.0014
936 COVID-19 239 0.0014
937 VISUAL ACUITY REDUCED 45 0.0014
938 PANCREATIC CARCINOMA 39 0.0013
939 OSTEONECROSIS 44 0.0013
940 LUNG NEOPLASM MALIGNANT 55 0.0013
941 IRRITABILITY 79 0.0013
942 INFLUENZA LIKE ILLNESS 108 0.0013
943 FEELING ABNORMAL 309 0.0013
944 WEIGHT INCREASED 287 0.0013
945 DYSSTASIA 37 0.0013
946 NASAL CONGESTION 74 0.0013
947 NASOPHARYNGITIS 231 0.0013
948 ROAD TRAFFIC ACCIDENT 52 0.0012
949 INTENTIONAL PRODUCT MISUSE 107 0.0012
950 PRODUCT USE ISSUE 226 0.0012
951 DEVICE DISLOCATION 52 0.0012
952 ABNORMAL DREAMS 33 0.0012
953 ABORTION SPONTANEOUS 47 0.0012
954 DRY EYE 58 0.0012
955 SURGERY 67 0.0011
956 OCULAR HYPERAEMIA 54 0.0011
957 DRUG INEFFECTIVE 1479 0.0011
958 WITHDRAWAL SYNDROME 47 0.0011
959 ILLNESS 115 0.0011
960 URTICARIA 184 0.0011
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 77 0.0011
962 DRUG DEPENDENCE 174 0.0011
963 HOSPITALISATION 163 0.0011
964 EYE SWELLING 39 0.0010
965 TREATMENT FAILURE 86 0.0010
966 ANGER 35 0.0010
967 EYE PAIN 56 0.0010
968 BREAST CANCER 90 0.0010
969 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
970 THROAT IRRITATION 42 0.0009
971 VAGINAL HAEMORRHAGE 40 0.0009
972 INJECTION SITE MASS 34 0.0009
973 UNDERDOSE 67 0.0009
974 DRUG WITHDRAWAL SYNDROME 76 0.0009
975 ADVERSE EVENT 79 0.0009
976 DISEASE RECURRENCE 39 0.0008
977 THERAPEUTIC RESPONSE DECREASED 48 0.0008
978 DEVICE MALFUNCTION 55 0.0008
979 ADVERSE DRUG REACTION 68 0.0008
980 RHEUMATOID ARTHRITIS 85 0.0007
981 INCORRECT DOSE ADMINISTERED 165 0.0007
982 PRODUCT SUBSTITUTION ISSUE 40 0.0007
983 MULTIPLE SCLEROSIS 33 0.0007
984 PRODUCT DOSE OMISSION ISSUE 187 0.0006
985 THERAPY INTERRUPTED 45 0.0006
986 MULTIPLE SCLEROSIS RELAPSE 42 0.0006
987 PRODUCT QUALITY ISSUE 80 0.0006
988 INJECTION SITE REACTION 36 0.0005
989 PSORIASIS 63 0.0005
990 PROSTATE CANCER 36 0.0004
991 INJECTION SITE PAIN 136 0.0004
992 INJECTION SITE ERYTHEMA 54 0.0004
993 DRUG DOSE OMISSION 64 0.0004
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72 0.0004
995 NO ADVERSE EVENT 46 0.0003